---
title: "Kids Medical Systems Ltd (540812) — Share Price, Financials & Analysis"
symbol: "540812"
company: "Kids Medical Systems Ltd"
canonical: "https://tapetide.com/stocks/540812"
isin: "INE457Y01014"
bse_code: "540812"
sector: "Healthcare"
industry: "Healthcare Services"
generated_at: "2026-09-13T18:37:42.989Z"
---

# Kids Medical Systems Ltd (540812)

Canonical page: https://tapetide.com/stocks/540812

## Company

- **BSE Code:** 540812
- **ISIN:** INE457Y01014
- **Sector:** Healthcare
- **Industry:** Healthcare Services
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** thekidsclinic.in

## Latest Price

## Key Insights

### Strengths

- Company is almost debt free.
- Stock is trading at 0.78 times its book value

### Weaknesses

- Company has low interest coverage ratio.
- Company has a low return on equity of -0.41% over last 3 years.

## Growth Rates

| Metric | 1Y | 5Y |
| --- | --- | --- |
| net income growth | -500% | 13% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Sep 2018 | Mar 2019 |
| --- | --- | --- | --- |
| Sales | 0.22 | 0.16 | 0.18 |
| Expenses | 0.45 | 0.24 | 0.42 |
| Operating Profit | -0.23 | -0.08 | -0.24 |
| OPM % | -104.55 | -50 | -133.33 |
| Other Income | 0 | 0 | 0 |
| Interest | 0.04 | 0 | 0.01 |
| Depreciation | 0.02 | 0 | 0 |
| Profit before tax | -0.29 | -0.08 | -0.25 |
| Tax % | 0 | 0 | 0 |
| Net Profit | -0.29 | -0.08 | -0.25 |
| EPS in Rs | -0.41 | -0.11 | -0.35 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2022 | Mar 2023 | Mar 2024 |
| --- | --- | --- | --- | --- | --- | --- |
| Sales | 2.24 | 0.51 | 0.34 | 0 | 0 | 0 |
| Expenses | 2.04 | 0.74 | 0.67 | 0.02 | 0.01 | 0.07 |
| Operating Profit | 0.2 | -0.23 | -0.33 | -0.02 | -0.01 | -0.07 |
| OPM % | 8.93 | -45.1 | -97.06 | — | — | — |
| Other Income | -0.01 | 0.04 | 0 | 0 | 0 | 0.01 |
| Interest | 0 | 0.05 | 0.01 | 0 | 0 | 0 |
| Depreciation | 0.07 | 0.04 | 0 | 0 | 0 | 0 |
| Profit before tax | 0.12 | -0.28 | -0.34 | -0.02 | -0.01 | -0.06 |
| Tax % | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 0.12 | -0.29 | -0.34 | -0.02 | -0.01 | -0.06 |
| EPS in Rs | 99.17 | -0.41 | -0.48 | -0.03 | -0.01 | -0.08 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2022 | Mar 2023 | Mar 2024 |
| --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 0.01 | 7.09 | 7.09 | 7.09 | 7.09 | 7.09 |
| Reserves | 0.47 | 4.03 | 0.15 | 0.28 | 0.27 | 0.22 |
| Borrowings | 0.6 | 0.3 | 0.37 | 0.26 | 0.26 | 0.26 |
| Other Liabilities | 2.65 | 0.11 | 0.22 | 0.27 | 0.28 | 0.3 |
| Total Liabilities | 3.73 | 11.53 | 7.83 | 7.9 | 7.9 | 7.87 |
| Fixed Assets | 0.23 | 0.19 | 0.19 | 0.19 | 0.19 | 0.19 |
| CWIP | 2.48 | 3.54 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 1.02 | 7.8 | 7.64 | 7.71 | 7.71 | 7.68 |
| Total Assets | 3.73 | 11.53 | 7.83 | 7.9 | 7.9 | 7.87 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2022 | Mar 2023 | Mar 2024 |
| --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 2.27 | -9.49 | -0.12 | 0 | 0 | 0 |
| Cash from Investing Activity | -2.49 | -1.08 | -0.01 | 0 | 0 | 0 |
| Cash from Financing Activity | 0.6 | 10.37 | 0.06 | 0 | 0 | 0 |
| Net Cash Flow | 0.38 | -0.2 | -0.07 | 0 | 0 | 0.01 |
| Free Cash Flow | -0.23 | -10.55 | -0.12 | 0 | 0 | 0 |
| CFO/OP | 1135 | 4126 | 36 | 0 | 0 | 0 |

### Ratios

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2022 | Mar 2023 | Mar 2024 |
| --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 34.22 | 157.45 | 236.18 | — | — | — |
| Cash Conversion Cycle | 34.22 | 157.45 | 236.18 | — | — | — |
| Working Capital Days | -439.96 | 4959.71 | 7128.24 | — | — | — |
| ROCE % | — | -3.68 | -3.47 | — | -0.13 | -0.79 |

## Shareholding Pattern

### annual

| Category | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 55.41% | 55.41% | 55.41% | 55.41% | 55.41% | 55.41% | 55.41% | 55.41% |
| FIIs | 0.34% | 0.34% | 0.34% | 0.34% | 0.34% | 0.34% | 0.34% | 0% |
| DIIs | 0% | 0% | 21.83% | 0% | 0% | 0% | 0% | 0% |
| Public | 44.25% | 44.25% | 22.42% | 44.24% | 44.24% | 44.24% | 44.24% | 44.58% |
| No. of Shareholders | 95 | 92 | 96 | 93 | 93 | 93 | 93 | 92 |

### Quarterly

| Category | Dec 2019 | Mar 2020 | Sep 2020 | Mar 2021 | Sep 2021 | Mar 2022 | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 55.41% | 55.41% | 55.41% | 55.41% | 55.41% | 55.41% | 55.41% | 55.41% | 55.41% | 55.41% | 55.41% | 55.41% |
| FIIs | 0.34% | 0.34% | 0.34% | 0.34% | 0.34% | 0.34% | 0.34% | 0.34% | 0.34% | 0.34% | 0.34% | 0% |
| DIIs | 0% | 21.83% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 44.25% | 22.42% | 44.24% | 44.24% | 44.24% | 44.24% | 44.24% | 44.24% | 44.24% | 44.24% | 44.24% | 44.58% |
| No. of Shareholders | 96 | 96 | 93 | 93 | 93 | 93 | 93 | 93 | 93 | 93 | 93 | 92 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Sell
- **Buy / Neutral / Sell:** 3 / 11 / 5

### Moving Averages — summary: **Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 10.05 | Sell |
| EMA (10) | 11.12 | Sell |
| SMA (20) | 16.69 | Sell |
| EMA (20) | 18.36 | Sell |
| SMA (50) | — | Neutral |
| EMA (50) | — | Neutral |
| SMA (100) | — | Neutral |
| EMA (100) | — | Neutral |
| SMA (200) | — | Neutral |
| EMA (200) | — | Neutral |

### Oscillators — summary: **Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 1 | Buy |
| MACD (12,26,9) | — | Neutral |
| Stochastic (14,3,3) | 0 | Buy |
| ADX (14) | — | Neutral |
| Williams %R (14) | -100 | Buy |
| ATR (14) | 1.38 | High Volatility |
| ROC (12) | -46.62 | Sell |
| Stoch RSI (14) | — | Neutral |
| UO (7,14,28) | — | Neutral |

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-04-15 | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=af7d3a01-3e59-4a9f-94b4-327f0d7d8519.pdf) |
| 2026-03-31 | [Closure of Trading Window](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=94adadda-8e72-434b-abe3-9714ba454bc1.pdf) |
| 2025-07-08 | [Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=db5a9dc5-1b0b-45d5-9b42-111334b7514c.pdf) |
| 2025-06-27 | [General Announcement Cum Clarification Regarding Appointment And Resignation Of Company Secretary (CS).](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7d083ff8-b8eb-4a5a-ae73-da2233a5496a.pdf) |
| 2025-06-13 | [Board Meeting Outcome for APPOINTMENT OF COMPLIANCE OFFICER](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=38aa86cb-c8d9-478e-87fd-08bb8d54e653.pdf) |
| 2025-06-06 | [Board Meeting Outcome for Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a296d662-4516-4f28-877f-704571b56b00.pdf) |
| 2025-06-06 | [Results From September 2019 To March 2023](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1b9a2143-7835-44a8-99f3-02317ebade7d.pdf) |
| 2025-04-28 | [Board Meeting Intimation for Intimation Of Board Meeting Dated 02Nd May 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=91222676-3457-4587-b05f-0d7fa36a550f.pdf) |
| 2025-03-25 | [Shareholder Meeting / Postal Ballot-Outcome of AGM](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=217067f4-b954-4ea0-8916-116620269bb3.pdf) |
| 2025-03-25 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=286aee22-a8df-4bc0-8b58-250b860f3980.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 8 Jul 2025 - Application to shift registered office from Gujarat to Maharashtra rejected due to compliance violations. | [Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order 8 Jul 2025 - Application to shift registered office from Gujarat to Maharashtra rejected due to compliance violations.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/db5a9dc5-1b0b-45d5-9b42-111334b7514c.pdf) |
| 6 Jun 2025 - Board approved standalone financial results from Sept 2019 to March 2023 with limited review reports. | [Board Meeting Outcome for Outcome 6 Jun 2025 - Board approved standalone financial results from Sept 2019 to March 2023 with limited review reports.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a296d662-4516-4f28-877f-704571b56b00.pdf) |
| 6 Jun 2025 - Approval of standalone financial results from 2019 to 2023, audited and unaudited, per SEBI regulations. | [Results From September 2019 To March 2023 6 Jun 2025 - Approval of standalone financial results from 2019 to 2023, audited and unaudited, per SEBI regulations.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/1b9a2143-7835-44a8-99f3-02317ebade7d.pdf) |
| 30 Jan - Unaudited Q3 results; interim dividend Rs.195/share (incl. Rs.25 special), record date Feb 5, 2026; payout by Feb 27, 2026. | [Board Meeting Outcome for Unaudited Financial Results For The Quarter Ended December 31, 2025 And Interim Dividend For Financial Year 2025-26 30 Jan - Unaudited Q3 results; interim dividend Rs.195/share (incl. Rs.25 special), record date Feb 5, 2026; payout by Feb 27, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/af27de40-6cf5-4ad4-8336-25dc2034f425.pdf) |
| 30 Jan - Q3 sales ₹1,262 crore (+1%); PAT ₹301 crore (+12%); interim dividend ₹195/share (₹25 special). | [Announcement under Regulation 30 (LODR)-Press Release / Media Release 30 Jan - Q3 sales ₹1,262 crore (+1%); PAT ₹301 crore (+12%); interim dividend ₹195/share (₹25 special).](https://www.bseindia.com/xml-data/corpfiling/AttachHis/71d161ef-d12e-4696-ad8f-619cb9487c0b.pdf) |
| 30 Jan - Interim dividend Rs.195/share (incl. Rs.25 special); record date Feb 5, 2026; declared Jan 30, 2026. | [Communication In Respect Of Deduction Of Tax At Source (TDS) On The Amount Of Dividend Income From Procter & Gamble Hygiene And Health Care Limited For The FY 2025-26 30 Jan - Interim dividend Rs.195/share (incl. Rs.25 special); record date Feb 5, 2026; declared Jan 30, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/37781a8e-3d06-4426-91ab-7736c0e9c2a5.pdf) |
| 30 Jan - Declared interim dividend ₹195/share (₹25 special); Q3 Dec 31, 2025 results; record date Feb 5, 2026. | [Corporate Action-Board approves Dividend 30 Jan - Declared interim dividend ₹195/share (₹25 special); Q3 Dec 31, 2025 results; record date Feb 5, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/30ca5379-c634-451d-85b5-7c9740193f3c.pdf) |
| 27 Jun 2025 - Company Secretary resigns and re-appointed due to name change after marriage on June 13, 2025. | [General Announcement Cum Clarification Regarding Appointment And Resignation Of Company Secretary (CS). 27 Jun 2025 - Company Secretary resigns and re-appointed due to name change after marriage on June 13, 2025.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/7d083ff8-b8eb-4a5a-ae73-da2233a5496a.pdf) |
| 24 Feb - Ghanashyam Hegde to become VP & Associate General Counsel for India, Middle East, Turkey & Africa effective July 1, 2026. | [Announcement under Regulation 30 (LODR)-Change in Management 24 Feb - Ghanashyam Hegde to become VP & Associate General Counsel for India, Middle East, Turkey & Africa effective July 1, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/d434089b-516b-434c-85fb-7191abe16db6.pdf) |
| 24 Feb - Ghanashyam Hegde to become VP & Associate General Counsel (India, ME, Turkey & Africa) effective July 1, 2026. | [Announcement under Regulation 30 (LODR)-Change in Directorate 24 Feb - Ghanashyam Hegde to become VP & Associate General Counsel (India, ME, Turkey & Africa) effective July 1, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/04fc20f9-3acb-4066-a0d2-4b152bc37160.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Sep 2024 | [Concall - Sep 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/505209a6-6b93-4cd8-9694-e0ab2bd2b476.pdf) |
| Sep 2023 | [Concall - Sep 2023](https://www.bseindia.com/xml-data/corpfiling/AttachHis/d352e79b-fb88-47fb-8f54-4d7366ecc0e4.pdf) |
| Mar 2019 | [Concall - Mar 2019](https://www.bseindia.com/xml-data/corpfiling/AttachHis/1f46db9c-ca85-43a8-b4ef-71066c16bbb0.pdf) |
| Jun 2025 | [Concall - Jun 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/c01c3021-876d-4044-8b0d-c63334543e0a.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from nse | [Financial Year 2011 from nse](https://archives.nseindia.com/annual_reports/AR_PGHH_2010_2011_27022012101414.zip) |
| from bse | [Financial Year 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/99357d61-b70d-47e8-99f7-56d10b4d06bb.pdf) |
| from bse | [Financial Year 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/80228e8c-6a88-48ed-ad15-fb9980da909f.pdf) |
| from bse | [Financial Year 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/f07bd3ab-a134-4666-afde-a62a05b1301c.pdf) |
| from bse | [Financial Year 2022 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/c0dfdeaf-249c-4a36-974c-c42246b33727.pdf) |
| from bse | [Financial Year 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/500459/72661500459.pdf) |
| from bse | [Financial Year 2020 from bse](https://www.bseindia.com/bseplus/AnnualReport/500459/67418500459.pdf) |
| from bse | [Financial Year 2019 from bse](https://www.bseindia.com/bseplus/AnnualReport/500459/5004590619.pdf) |
| from bse | [Annual Report 2019 from bse](https://www.bseindia.com/bseplus/AnnualReport/540812/5408120319.pdf) |
| from bse | [Financial Year 2018 from bse](https://www.bseindia.com/bseplus/AnnualReport/500459/5004590618.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T18:37:42.989Z.